-
1دورية أكاديمية
المؤلفون: Liu, M C1 (AUTHOR), Klein, E2 (AUTHOR), Hubbell, E3 (AUTHOR), Maddala, T3 (AUTHOR), Aravanis, A M3 (AUTHOR), Beausang, J F4 (AUTHOR), Filippova, D4 (AUTHOR), Gross, S4 (AUTHOR), Jamshidi, A4 (AUTHOR), Kurtzman, K4 (AUTHOR)
المصدر: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
مصطلحات موضوعية: *CELL-free DNA, *DNA, *MOLECULAR oncology
-
2دورية أكاديمية
المؤلفون: Schrodi, S.1 (AUTHOR) schrodi@ibe.med.uni-muenchen.de, Braun, M.2 (AUTHOR), Andrulat, A.2 (AUTHOR), Harbeck, N.3 (AUTHOR), Mahner, S.3 (AUTHOR), Kiechle, M.4 (AUTHOR), Klein, E.4 (AUTHOR), Schnelzer, A.5 (AUTHOR), Schindlbeck, C.3,6 (AUTHOR), Bauerfeind, I.7 (AUTHOR), Schubert-Fritschle, G.1 (AUTHOR), Nekljudova, V.8 (AUTHOR), Mayr, D.9 (AUTHOR), Weichert, W.10 (AUTHOR), Denkert, C.11 (AUTHOR), Loibl, S.8,12 (AUTHOR), Engel, J.1 (AUTHOR)
المصدر: Annals of Oncology. Nov2021, Vol. 32 Issue 11, p1410-1424. 15p.
مصطلحات موضوعية: *BREAST cancer, *HORMONE receptors, *HORMONE receptor positive breast cancer, *CANCER prognosis, *PROGNOSIS, *OVERALL survival
-
3دورية أكاديمية
المؤلفون: Michel, L.1 (AUTHOR), Romar, P.1 (AUTHOR), Feisst, M.2 (AUTHOR), Hamberger, D.3 (AUTHOR), Schwarz, D.4 (AUTHOR), Kurre, E.1 (AUTHOR), Klein, E.1 (AUTHOR), Breckwoldt, M.O.4 (AUTHOR), Priester, A.4 (AUTHOR), Weiler, M.5 (AUTHOR), Smetanay, K.6 (AUTHOR), Fremd, C.1 (AUTHOR), Jäger, D.1 (AUTHOR), Bendszus, M.4 (AUTHOR), Marmé, F.7 (AUTHOR), Schneeweiss, A.1 (AUTHOR)
المصدر: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1257-S1258. 2p.
مصطلحات موضوعية: *ADJUVANT chemotherapy, *PERIPHERAL neuropathy, *BREAST cancer, *CHEMOTHERAPY complications, *COMPRESSION stockings
-
4دورية أكاديمية
المؤلفون: Ettl, J1 (AUTHOR), Blohmer, J-U2 (AUTHOR), Denkert, C3 (AUTHOR), Beier, L4 (AUTHOR), Klein, E1 (AUTHOR), Neuser, P5 (AUTHOR), Keller, M4 (AUTHOR), Untch, M6 (AUTHOR), Wittenberg, M5 (AUTHOR), Kiechle, M1 (AUTHOR)
المصدر: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
مصطلحات موضوعية: *HORMONE receptor positive breast cancer, *BREAST cancer, *RISK assessment, *LONGITUDINAL method, *CIRCULATING tumor DNA, *CANCER chemotherapy